Sirdalud (Tizanidine) With 20 Tablets Of 2Mg S

Category

Medications

Line

Neuroleptics

Brand

Sirdalud

Molecule

Tizanidine

Presentation

20 Tablets of 2 mg

Laboratory

Novartis

Indications

Sirdalud (Tizanidine) is indicated for the treatment of muscle spasms associated with acute and chronic musculoskeletal disorders. Its action is based on the inhibition of neurotransmitter release in the spinal cord, resulting in a relaxing effect on skeletal muscles. This medication is commonly used in conditions such as multiple sclerosis, spinal cord injuries, and other conditions that cause spasticity. It is important that treatment be supervised by a physician, who can adjust the dose according to the patient's response and the severity of the treated condition.

Composition

Each tablet contains 2 mg of Tizanidine as the active ingredient. Additionally, it may contain excipients such as starch, talc, and other compounds that facilitate the formulation of the medication.

Contraindications

Sirdalud is contraindicated in patients who are hypersensitive to Tizanidine or any of the product's excipients. Its use is not recommended in patients with severe liver failure, as its metabolism primarily occurs in the liver. Likewise, caution should be exercised in patients with a history of liver diseases or those who are taking medications that may interfere with its metabolism.

Precautions

Special care should be taken in patients over 65 years of age, as they may be more susceptible to the sedative effects of Tizanidine. Additionally, it is recommended to avoid alcohol consumption during treatment, as it can enhance the adverse effects of the medication. Regular medical follow-up is important to adjust the dose and evaluate the effectiveness of the treatment.

Storage

Store in a cool, dry place, at a temperature not exceeding 30°C. Keep out of reach of children.

Prescription required.

Consult your doctor.